Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03928756 · ClinicalTrials.gov registry record · NA
Adaptive Interventions for Prevention/Intervention for Youth Substance Abuse
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT03928756: Completed NA study, sponsored by University of Michigan.
NCT03928756 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03928756, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The main aim of this formative study is to test and iteratively refine a new mobile phone app, which delivers assessments and tailored intervention content. The study will use social media advertisements to recruit a total of 40 youth between the ages of 16-24 years. Those screening positive for past-month binge drinking or marijuana use will be invited to complete a baseline survey, download and use the app for 30 days, and complete a follow-up survey about the app functionality, design and content, and preliminary outcomes (intentions and importance of reducing use).
Primary Outcome
Change in intentions to reduce alcohol use will be assessed using a 10-point validated Likert item which asks participants to rate their current likelihood of cutting back on their alcohol use. (a score of 1 is equivalent to not at all likely and a score of 10 is very likely)
Interventions
- BEHAVIORAL Push Notifications with Tailored Intervention Content
- BEHAVIORAL Push Notifications with Engaging, Non-therapeutic Content
- BEHAVIORAL No Push Notifications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2019-08-12 |
| Est. Completion | 2019-10-17 |
| Phase | NA |
What the finished NCT03928756 record still lists
NCT03928756 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Push Notifications with Tailored Intervention Content is the first listed.
NCT03928756 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03928756 about?
NCT03928756 is a clinical study titled "Adaptive Interventions for Prevention/Intervention for Youth Substance Abuse". The main aim of this formative study is to test and iteratively refine a new mobile phone app, which delivers assessments and tailored intervention content. The study will use social media advertisements to recruit a total of 40 youth between the ages of 16-24 years. Those screening positive for pas...
What is the current status of trial NCT03928756?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2019-08-12. Estimated completion is 2019-10-17.
What interventions are being tested in trial NCT03928756?
The interventions under investigation include: Push Notifications with Tailored Intervention Content (BEHAVIORAL), Push Notifications with Engaging, Non-therapeutic Content (BEHAVIORAL), No Push Notifications (BEHAVIORAL).
Who is sponsoring clinical trial NCT03928756?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03928756's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI